5-[4-chloro-3-(4,4-dimethylpiperidin-1-yl)indazol-1-yl]sulfonyl-N,N-dimethylthiophene-2-sulfonamide
C20H25ClN4O4S3 — CID 175714173
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[4-chloro-3-(4,4-dimethylpiperidin-1-yl)indazol-1-yl]sulfonyl-N,N-dimethylthiophene-2-sulfonamide
5-[4-chloro-3-(4,4-dimethylpiperidin-1-yl)indazol-1-yl]sulfonyl-N,N-dimethylthiophene-2-sulfonamide (PubChem CID 175714173) has the molecular formula C20H25ClN4O4S3 and a molecular weight of 517.10 g/mol. Its IUPAC name is 5-[4-chloro-3-(4,4-dimethylpiperidin-1-yl)indazol-1-yl]sulfonyl-N,N-dimethylthiophene-2-sulfonamide.
Molecular Properties
| Compound Name | 5-[4-chloro-3-(4,4-dimethylpiperidin-1-yl)indazol-1-yl]sulfonyl-N,N-dimethylthiophene-2-sulfonamide |
|---|---|
| PubChem CID | 175714173 |
| Molecular Formula | C20H25ClN4O4S3 |
| Molecular Weight | 517.10 g/mol |
| Exact Mass | 516.07 |
| IUPAC Name | 5-[4-chloro-3-(4,4-dimethylpiperidin-1-yl)indazol-1-yl]sulfonyl-N,N-dimethylthiophene-2-sulfonamide |
| SMILES | CN(C)S(=O)(=O)c1ccc(S(=O)(=O)n2nc(N3CCC(C)(C)CC3)c3c(Cl)cccc32)s1 |
| InChI | InChI=1S/C20H25ClN4O4S3/c1-20(2)10-12-24(13-11-20)19-18-14(21)6-5-7-15(18)25(22-19)32(28,29)17-9-8-16(30-17)31(26,27)23(3)4/h5-9H,10-13H2,1-4H3 |
| InChIKey | VTVARHSBBQTIFJ-UHFFFAOYSA-N |
| XLogP | 3.86 |
| TPSA | 92.58 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 517.10 |
| LogP ≤ 5 | 3.86 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175714173 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.